SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies

The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene has raised alarms about the effectiveness of current medical countermeasures. To address this concern, we measured neutr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lusvarghi, Sabrina, Pollett, Simon D., Neerukonda, Sabari Nath, Wang, Wei, Wang, Richard, Vassell, Russell, Epsi, Nusrat J., Fries, Anthony C., Agan, Brian K., Lindholm, David A., Colombo, Christopher J., Mody, Rupal, Ewers, Evan C., Lalani, Tahaniyat, Ganesan, Anuradha, Goguet, Emilie, Hollis-Perry, Monique, Coggins, Si’Ana A., Simons, Mark P., Katzelnick, Leah C., Wang, Gregory, Tribble, David R., Bentley, Lisa, Eakin, Ann E., Broder, Christopher C., Erlandson, Karl J., Laing, Eric D., Burgess, Timothy H., Mitre, Edward, Weiss, Carol D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995032/
https://www.ncbi.nlm.nih.gov/pubmed/35380448
http://dx.doi.org/10.1126/scitranslmed.abn8543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995032/
https://www.ncbi.nlm.nih.gov/pubmed/35380448
http://dx.doi.org/10.1126/scitranslmed.abn8543

Ejemplares similares